Caligor Rx partners with pharmaceutical and biotechnology companies to develop, implement, and manage ethically and regulatory compliant Global Access Programs. These programs, often referred to as Compassionate Use or Expanded Access, provide access to unlicensed medicines outside of the clinical trial or commercial setting for patients in need worldwide.
Our experienced leadership team offers valued strategic guidance and leverages their insight to help sponsors “bridge the gap” between medicines with limited availability and patients in need.
Caligor’s full service access solution blends the appropriate components of clinical trial operations with global distribution, to provide an optimized and personalized approach to supporting access including use of our innovative web based access portal which provides for ease of use by physicians, site personnel and sponsors.
Partnering with Caligor Rx relieves sponsors of the significant resources required to manage global access, allowing them to remain focused on clinical development which ultimately brings innovative and life-saving medicines to patients in need.